NL – Lilly’s Pemetrexed patent is valid
On 16 January 2019, the District Court of The Hague ruled that the Dutch part of Eli Lilly and Company’s patent EP 1 313 508 is valid. The judgment was handed down in an invalidation action brought by Sandoz International GmbH. EP 508 relates to the use of pemetrexed in combination therapy with vitamin B12…